Cited by 435Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and PathologyCoenzyme Q10 studies and effects

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

Haas, Richard H., Nasirian, Fatemeh, Nakano, Kazutoshi, Ward, David, Pay, Mary, Hill, Robert, Shults, Clifford W.·1995·Annals of Neurology

DOI 10.1002/ana.410370604

Open this paper in CoChat — free account

Abstract

Following the discovery of inhibition of electron transport complex I by the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP), which produces a parkinsonian syndrome in humans, monkeys, and mice, several laboratories have reported abnormalities of complex I and other electron transport complexes (ETCs) in various tissues from patients with Parkinson's disease (PD). Criticism of the significance of these findings in the etiology of PD has centered on whether drug treatments or the debilitation of the disease process itself produced the low ETC activities. We present results from a blinded study of platelet mitochondrial ETC activities in 18 early untreated PD patients and 18 age‐ and sex‐matched controls and in 13 spousal controls. Lower complex I activity in platelet mitochondria of PD patients was seen in early untreated disease and thus cannot be due to debilitation or drug therapy. Home environmental factors seem an unlikely explanation for the reduced complex I activity in PD patients but have not been excluded. Complex II/III activity was also reduced by 20% in PD compared with age‐/sex‐matched controls. The low complex I and II/III activities in platelet mitochondria appear to be related to the etiology of PD.

Integrity signals

Registry

Crossref · 10.1002/ana.410370604

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 755
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., SATO, T. A., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 735
Spectrophotometric Assay of Cytochrome c Oxidase
Smith, L. (1955) · Methods of biochemical analysis · doi:10.1002/9780470110188.ch13 · Cited by 506
Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients
Shoffner, J. M., Brown, M. D., Torroni, A., Lott, M. T., Cabell, M. F., Mirra, S. S., Beal, M. F., Yang, C.-C., Gearing, M., Salvo, R., et al. (1993) · Genomics · doi:10.1006/geno.1993.1299 · Cited by 450

Show all 47 references

Research works printed but not linked: 1

Lang AET, 1989, Quantification of neurological deficit, 289

Sorted by citations

Items 201–300 of 434

Assessment of Platelet Respiration as Emerging Biomarker of Disease
Petruş, A., Lighezan, D. L., Dănilă, M. D., Duicu, O., Sturza, A., Muntean, D. M., & Ioniță, I. (2019) · Physiological Research · doi:10.33549/physiolres.934032 · Cited by 47
MITOCHONDRIAL COMPLEX I, II/III, AND IV ACTIVITIES IN FAMILIAL AND SPORADIC PARKINSON'S DISEASE
Hanagasi, H. A., AYRIBAS, D., Baysal, K., & Emre, M. (2005) · International Journal of Neuroscience · doi:10.1080/00207450590523017 · Cited by 45
Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology
De, R., Mazumder, S., & Bandyopadhyay, U. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09561-1 · Cited by 47
Mitochondrial dysfunction and possible treatments in Parkinson's disease—a review
Shults, C. W. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.028 · Cited by 44
Self-citation
Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders
Palin, E., Paetau, A. E., & Suomalainen, A. (2013) · Brain · doi:10.1093/brain/awt160 · Cited by 46
Biochemical Analysis of Cybrids Expressing Mitochondrial DNA from Contursi Kindred Parkinson's Subjects
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Binder, D. R., Bennett, J. P., Iorio, G. D., Golbe, L. I., & Parker, W. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7674 · Cited by 43
Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
González‐Casacuberta, I., Juárez‐Flores, D. L., Morén, C., & Garrabou, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00894 · Cited by 44
Novel mitochondrial DNA mutations in Parkinson's disease
Richter, G., Sonnenschein, A., Grünewald, T. G. P., Reichmann, H., & Janetzky, B. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200060 · Cited by 42
Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion
Tsuboi, K., Kimber, T. A., & Shults, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02219-8 · Cited by 41
Self-citation
Dietary Olive and Perilla Oils Affect Liver Mitochondrial DNA Methylation in Large Yellow Croakers
Liao, K., Yan, J., Mai, K., & Ai, Q. (2015) · Journal of Nutrition · doi:10.3945/jn.115.216481 · Cited by 41
Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: An immunohistochemical and morphometric study
Itoh, K., Weis, S., Mehraein, P., & Müller‐Höcker, J. (1997) · Movement Disorders · doi:10.1002/mds.870120104 · Cited by 41
A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
Norwitz, N. G., Dearlove, D., Lü, M., Clarke, K., Dawes, H., & Hu, M. T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.584130 · Cited by 43
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders
Rimessi, A., Patergnani, S., Morciano, G., Carinci, M., Leo, S., & Pinton, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339473 · Cited by 41
Mitochondrial dysfunction – a pathogenetic factor in Parkinson’s disease
Reichmann, H., & Janetzky, B. (2000) · Journal of Neurology · doi:10.1007/pl00007763 · Cited by 39
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 44
Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo
Kim, H.-W., Choi, W.-S., Sorscher, N., Park, H. J., Tronche, F., Palmiter, R. D., & Xia, Z. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.008 · Cited by 41
New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders
Bjarkam, C. R., Sørensen, J. C., Sunde, N. A., Geneser, F. A., & Østergaard, K. (2001) · Biogerontology · doi:10.1023/a:1011565207964 · Cited by 37
The Effect of Coenzyme Q10 Therapy in Parkinson Disease Could Be Symptomatic
Horstink, M. W. I. M., & van Engelen, B. G. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1170-b · Cited by 37
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
Gautam, D., Naik, U. P., Naik, M. U., Yadav, S. K., Chaurasia, R. N., & Dash, D. (2023) · Biomolecules · doi:10.3390/biom13111609 · Cited by 38
Platelet mitochondrial evaluation during cytochrome c and dichloroacetate treatments of MELAS
Nakano, K., Tarashima, M., Tachikawa, E., Noda, N., Nakayama, T., Sasaki, K., Mizoguchi, E., Matsuzaki, M., & Ōsawa, M. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.10.002 · Cited by 36
Self-citation
Distribution of Coenzyme Q Homologues in Brain
Albano, C. B., Muralikrishnan, D., & Ebadi, M. (2002) · Neurochemical Research · doi:10.1023/a:1015591628503 · Cited by 36
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Bigi, A., Cascella, R., & Cecchi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371345 · Cited by 38
Does Mitochondrial DNA Play a Role in Parkinson's Disease? A Review of Cybrid and Other Supportive Evidence
Swerdlow, R. H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3948 · Cited by 35
Neuroprotection in PD—A role for dopamine agonists?
Schapira, A. H. V. (2003) · Neurology · doi:10.1212/wnl.61.6_suppl_3.s34 · Cited by 35
Brain Mitochondrial Complex I Inactivation by Oxidative Modification
Bautista, J., Corpas, R., Ramos, R., Cremades, O., Gutierrez-Gil, J. F., & Alegre, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3388 · Cited by 34
Mitochondrial respiratory chain dysfunction in various neuromuscular diseases
Jongpiputvanich, S., Sueblinvong, T., & Norapucsunton, T. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.06.014 · Cited by 34
Proteomic Approach to Studying Parkinson's Disease
Zhang, J., & Goodlett, D. R. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:3:271 · Cited by 34
A Machine Learning Approach to Parkinson’s Disease Blood Transcriptomics
Pantaleo, E., Monaco, A., Amoroso, N., Lombardi, A., Bellantuono, L., Urso, D., Giudice, C. L., Picardi, E., Tafuri, B., Nigro, S. L., et al. (2022) · Genes · doi:10.3390/genes13050727 · Cited by 32
Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism
Song, L., McMackin, M. Z., Nguyen, A., & Cortopassi, G. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.024 · Cited by 32
Ophthalmoplegia and leg myorhythmia in Whipple's disease: Report of a case
Rajput, A. H., & McHattie, J. D. (1997) · Movement Disorders · doi:10.1002/mds.870120120 · Cited by 32
Mitochondrial Dysfunction in Skin Fibroblasts from a Parkinson's Disease Patient with an alpha-Synuclein Triplication
Mak, S. K., Tewari, D., Tetrud, J. W., Langston, J. W., & Schüle, B. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11025 · Cited by 31
The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson’s disease
Sian‐Hülsmann, J., & Riederer, P. F. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02192-0 · Cited by 32
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients
Zago, E. D., Molin, A. D., Dimitri, G. M., Xumerle, L., Pirazzini, C., Bacalini, M. G., Maturo, M. G., Azevedo, T., Spasov, S., Gómez‐Garre, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05227-6 · Cited by 31
Neuroproteomics as a promising tool in Parkinson’s disease research
Pienaar, I. S., Daniels, W. M. U., & Götz, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0070-3 · Cited by 32
Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy
Mandel, S. A., Morelli, M., Halperin, I. J. Y., & Korczyn, A. D. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0036-z · Cited by 36
Mitochondrial Abnormalities and Oxidative Imbalance in Neurodegenerative Disease
Ogawa, O., Zhu, X., Perry, G. L., & Smith, M. A. (2002) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2002.41.pe16 · Cited by 31
The Role of Platelets in the Stimulation of Neuronal Synaptic Plasticity, Electric Activity, and Oxidative Phosphorylation: Possibilities for New Therapy of Neurodegenerative Diseases
Kopeikina, E., & Ponomarev, E. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.680126 · Cited by 34
Mitochondrial dysfunction in Parkinson’s disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750811040032 · Cited by 30
Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury
Cornille, E., Abou-Hamdan, M., Khrestchatisky, M., Nieoullon, A. L., Reggi, M. L. D., & Gharib, B. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-51 · Cited by 30
Normal platelet mitochondrial complex I activity in Huntington’s Disease
Powers, W. J., Haas, R., Le, T. P., Videen, T. O., Hershey, T. G., McGee‐Minnich, L., & Perlmutter, J. S. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.008 · Cited by 30
Self-citation
Cooperative interaction between ascorbate and glutathione during mitochondrial impairment in mesencephalic cultures
Ehrhart, J., & Zeevalk, G. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01954.x · Cited by 30
Cellular redox poise modulation; the role of coenzyme Q10, gene and metabolic regulation
Linnane, A. W., & Eastwood, H. T. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.035 · Cited by 30
The mitochondrial common deletion in Parkinson's disease and related movement disorders
Zhang, J., Montine, T. J., Smith, M. A., Siedlak, S. L., Gu, G., Robertson, D., & Perry, G. L. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00041-4 · Cited by 31
NEUROPROTECTIVE THERAPIES
Simon, D. K., & Standaert, D. G. (1999) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70117-6 · Cited by 30
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis
Iñarrea, P., Alarcia, R., Álava, M. A., Capablo, J. L., Casanova, A., Íñiguez, C., Iturralde, M., Larrodé, P., Martín, J., Mostacero, E., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8481-z · Cited by 29
The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects
Müller-Nedebock, A. C., Brennan, R. R., Venter, M., Pienaar, I. S., van der Westhuizen, F. H., Elson, J. L., Ross, O. A., & Bardien, S. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104495 · Cited by 30
β-Phenethylamine-A Phenylalanine Derivative in Brain-Contributes to Oxidative Stress by Inhibiting Mitochondrial Complexes and DT-Diaphorase: AnIn SilicoStudy
Mazumder, M. K., Paul, R. K., & Borah, A. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12113 · Cited by 28
Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities
Gautam, A. H., & Zeevalk, G. D. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.03.013 · Cited by 28
A cue to queue for CoQ?
Shults, C. W., & Schapira, A. H. V. (2001) · Neurology · doi:10.1212/wnl.57.3.375 · Cited by 28
Self-citation
Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi’s Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics
Szalárdy, L., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/498401 · Cited by 30
Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP
Samantaray, S., Knaryan, V. H., Butler, J. T., Ray, S. K., & Banik, N. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05091.x · Cited by 27
Hydrogen peroxide removal and glutathione mixed disulfide formation during metabolic inhibition in mesencephalic cultures
Ehrhart, J., & Zeevalk, G. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00355.x · Cited by 27
Platelets and the Role of P2X Receptors in Nociception, Pain, Neuronal Toxicity and Thromboinflammation
Rawish, E., & Langer, H. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126585 · Cited by 26
Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson's disease, but not Parkinson plus patients, from an Indian population
Varghese, M., Pandey, M., Samanta, A., Gangopadhyay, P. K., & Mohanakumar, K. P. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.021 · Cited by 26
Diabetes and Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes (MELAS): Radiolabeled Polymerase Chain Reaction Is Necessary for Accurate Detection of Low Percentages of Mutation
Smith, M. L., Hua, X.-Y., Marsden, D., Liu, D., Kennaway, N. G., Ngo, K.-Y., & Haas, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4222 · Cited by 29
Self-citation
MPTP
Royland, J. E., & Langston, J. W. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-477-1_6 · Cited by 26
Oxidative Stress and Mitochondrial Injury in Chronic Multisymptom Conditions: From Gulf War Illness to Autism Spectrum DisorderPreprint
Golomb, B. A. (2012) · Nature Precedings · doi:10.1038/npre.2012.6847.1 · Cited by 26
Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s Disease
Cervilla-Martínez, J. F., Gotor, J. J. R., Wypijewski, K. J., Fontán‐Lozano, Á., Wang, T., Santamaría, E., Fuller, W., & Mejı́as, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214018 · Cited by 25
Detection of Respiratory Chain Defects in Cultivated Skin Fibroblasts and Skeletal Muscle of Patients with Parkinson's Disease
Wiedemann, F. R., Winkler, K., Lins, H., Wallesch, C., & Kunz, W. S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07870.x · Cited by 25
Potential Role of Mic60/Mitofilin in Parkinson’s Disease
Laar, V. S. V., Otero, P. A., Hastings, T. G., & Berman, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00898 · Cited by 25
The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease
Gawęda-Walerych, K., & Żekanowski, C. (2014) · Current Genomics · doi:10.2174/1389202914666131210211033 · Cited by 23
Biomarkers in Parkinson’s disease
Dorsey, E. R., Holloway, R. G., & Ravina, B. M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.6.823 · Cited by 23
Energy Status, Ubiquitin Proteasomal Function, and Oxidative Stress During Chronic and Acute Complex I Inhibition with Rotenone in Mesencephalic Cultures
Zeevalk, G. D., & Bernard, L. P. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.662 · Cited by 23
Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity
Zeevalk, G. D., Bernard, L. P., & Nicklas, W. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00567-9 · Cited by 23
Effects of estrogens and androgens on mitochondria under normal and pathological conditions
Mohajeri, M., Martín-Jiménez, C., Barreto, G. E., & Sahebkar, A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.03.001 · Cited by 23
Simple synthesis of biocompatible biotinylated porous hexagonal ZnO nanodisc for targeted doxorubicin delivery against breast cancer cell: In vitro and in vivo cytotoxic potential
Patra, P., Mitra, S., Gupta, A. D., Pradhan, S., Bhattacharya, S., Ahir, M., Mukherjee, S., Sarkar, S., Roy, S., Chattopadhyay, S., et al. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.05.052 · Cited by 22
Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson’s Disease Penetrance
Zanon, A., Pramstaller, P. P., Hicks, A. A., & Pichler, I. (2018) · Parkinson s Disease · doi:10.1155/2018/8684906 · Cited by 21
Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
Bajracharya, R., Youngson, N. A., & Ballard, J. W. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081850 · Cited by 24
Biomarkers for Evaluation of Clinical Efficacy of Multipotential Neuroprotective Drugs for Alzheimer's and Parkinson's Diseases
Halperin, I. J. Y., Morelli, M., Korczyn, A. D., Youdim, M. B. H., & Mandel, S. A. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.033 · Cited by 22
New opportunities for antioxidants in amelioration of neurodegenerative diseases
Bhandari, U. R., Danish, S. M., Ahmad, S., Ikram, M., Nadaf, A., Hasan, N., Kesharwani, P., & Ahmad, F. J. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111961 · Cited by 24
The Role of Xenobiotics and Trace Metals in Parkinson’s Disease
Bjørklund, G., Dadar, M., Chirumbolo, S., & Aaseth, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01832-1 · Cited by 20
Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk
Müller-Nedebock, A. C., van der Westhuizen, F. H., Kõks, S., & Bardien, S. (2021) · Movement Disorders · doi:10.1002/mds.28475 · Cited by 21
Copper sulfate prevents tyrosine hydroxylase reduced activity and motor deficits in a Parkinson's disease model in mice.
Alcaraz-Zubeldia, M., Boll, M., Montes-López, S., Pérez‐Severiano, F., Martínez‐Lazcano, J. C., Dı́az-Ruiz, A., & Rı́os, C. (2009) · PubMed · Cited by 21
Neuroprotection in Parkinson’s disease: Myth or reality?
Voss, T., & Ravina, B. M. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0047-5 · Cited by 21
Mitochondrial DNA polymorphism in substantia nigra
Kapsa, R. M. I., Jean-François, M. J. B., Lertrit, P., Weng, S., Siregar, N. C., Ojaimi, J., Donnan, G. A., Masters, C. L., & Byrne, E. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00247-x · Cited by 21
Parkinson's Disease: Genetics and Pathogenesis
Testa, C. M. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn063 · Cited by 21
OXPHOS toxicogenomics and Parkinson's disease
López‐Gallardo, E., Iceta, R., Iglesias, E., Montoya, J., & Ruiz‐Pesini, E. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.06.004 · Cited by 19
Functional validation of a human GLUD2 variant in a murine model of Parkinson’s disease
Zhang, W., Gong, J., Ding, L., Zhang, Z., Pan, X., Chen, X. '., Guo, W., Zhang, X., Yang, X., Peng, G., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03043-2 · Cited by 21
Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat
Romero‐Ramos, M., Venero, J. L., Cano, J., & Machado, A. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00171-6 · Cited by 20
NMDA Receptors Modulate Dopamine Loss due to Energy Impairment in the Substantia Nigra but not Striatum
Zeevalk, G. D., Manzino, L., & Sonsalla, P. K. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7283 · Cited by 20
Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration
Pienaar, I. S., Schallert, T. J., Hattingh, S. M., & Daniels, W. M. U. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0247-4 · Cited by 19
Clinical trials aimed at detecting neuroprotection in Parkinson’s disease
Hauser, R. A., & Zesiewicz, T. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s58 · Cited by 19
Mitochondrial Dysfunction in Parkinson’s Disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, J. N., Trimmer, P. A., Tuttle, J. B., Bennett, J. P., Wooten, G. F., Davis, R. E., & Parker, W. D. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_11 · Cited by 19
Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease
Cabral, G. F., Schaan, A. P., Cavalcante, G. C., Sena-dos-Santos, C., de Souza, T. P., Port’s, N. M. D. S., Pinheiro, J. A. D. S., Ribeiro‐dos‐Santos, Â., & Vidal, A. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189839 · Cited by 18
Mitochondrial disfunction in Parkinson's disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20115703246 · Cited by 18
Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease
Bronstein, J. M., Paul, K. C., Yang, L., Haas, R., Shults, C. W., Le, T. P., & Ritz, B. R. (2015) · Movement Disorders · doi:10.1002/mds.26164 · Cited by 18
Self-citation
Na+/H+ exchanger inhibition modifies dopamine neurotransmission during normal and metabolic stress conditions
Rocha, M. A., Crockett, D. P., Wong, L., Richardson, J. R., & Sonsalla, P. K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05355.x · Cited by 19
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection
Blandini, F., Martignoni, E., Ricotti, R., Jeso, F. D., & Nappi, G. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00286-8 · Cited by 18
Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study
Rozani, V., Giladi, N., Gurevich, T., El‐Ad, B., Tsamir, J., Hemo, B., & Peretz, C. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.03.010 · Cited by 18
Mitochondrial mechanisms of redox cycling agents implicated in Parkinson’s disease
Lopert, P., & Patel, M. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1386-4 · Cited by 17
Alzheimer’s disease: A hypothesis on pathogenesis
Harman, D. (2000) · AGE · doi:10.1007/s11357-000-0017-6 · Cited by 16
Striatal 19S Rpt6 deficit is related to α-synuclein accumulation in MPTP-treated mice
Liu, B., Shi, Q., Ma, S., Feng, N., Li, J., Wang, L., & Wang, X. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.142 · Cited by 16
Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders
Michalak, S., Florczak‐Wyspianska, J., Rybacka-Mossakowska, J., Ambrosius, W., Osztynowicz, K., Baszczuk, A., Kozubski, W. P., & Wysocka, E. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9703574 · Cited by 15
α-Synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy
Shults, C. W., Barrett, J. M., & Fontaine, D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.006 · Cited by 15
Self-citation
Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
Zhang, Y., Li, J., Zhang, X. L., Song, D., & Tian, T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.614251 · Cited by 14
Coenzyme Q10 in Heart and Brain Diseases
Fedačko, J. (2011) · The Open Nutraceuticals Journal · doi:10.2174/1876396001104010069 · Cited by 14
Mitochondrial Therapy for Parkinson Disease
Rosenberg, R. N. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1523 · Cited by 14
Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model
O'Hanlon, M. E., Tweedy, C., Scialò, F., Bass, R., Sanz, A., & Smulders-Srinivasan, T. K. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105803 · Cited by 13
Mitochondrial DNA sequence variation is associated with free-living activity energy expenditure in the elderly
Tranah, G. J., Lam, E. T., Katzman, S. M., Nalls, M. A., Zhao, Y., Evans, D. S., Yokoyama, J. S., Pawlikowska, L., Kwok, P., Mooney, S. D., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.05.012 · Cited by 13
Platelet Mitochondrial Complex I and I+III Activities Do Not Correlate with Cerebral Mitochondrial Oxidative Metabolism
Powers, W. J., Haas, R., Le, T., Videen, T. O., Markham, J., & Perlmutter, J. S. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.179 · Cited by 13
Self-citation

Authors: Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W.
Affiliations: University of California San Diego (US)
Veterans Health Administration (US)
ORCID: Haas, Richard H.
Nakano, Kazutoshi
Ward, David
Hill, Robert
Venue: Annals of Neurology
Publisher: Wiley
Published: 1995-06
Volume: 37
Issue: 6
Pages: 714-722
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.410370604
OpenAlex: W2112777355
Cited by: 435
References: 47
Citations by year: 2026: 5 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 23 · 2018: 13 · 2017: 18 · 2016: 8 · 2015: 22 · 2014: 9 · 2013: 15 · 2012: 11
FWCI: 7.62
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 3417 d)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns029504-03)
National Institute of Neurological Disorders and Stroke (R01 NS29504)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
Keywords: Parkinson's disease, platelet mitochondria, mitochondrial electron transport chain, complex I, MPTP, etiology, mitochondrial dysfunction
MeSH terms: Adult, Aged, Blood Platelets, Citrate (si)-Synthase, Female, Humans, Male, Middle Aged, Mitochondria, Multienzyme Complexes, Oxidoreductases, Parkinson Disease, Smoking, Succinate Dehydrogenase, Electron Transport Complex III, NAD(P)H Dehydrogenase (Quinone), Electron Transport Complex II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks